The Journal of Contemporary Dental Practice

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 8 , ISSUE 5 ( July, 2007 ) > List of Articles

RESEARCH ARTICLE

Adjunctive Effects of Systemic Amoxicillin and Metronidazole with Scaling and Root Planing: A Randomized, Placebo Controlled Clinical Trial

Amir Moeintaghavi, Mohammad Reza Talebi-ardakani, Ahmad Haerian-ardakani, Hengame Zandi, Shokouh Taghipour, Hossein Fallahzadeh, Amir Pakzad, Nargess Fahami

Citation Information : Moeintaghavi A, Talebi-ardakani MR, Haerian-ardakani A, Zandi H, Taghipour S, Fallahzadeh H, Pakzad A, Fahami N. Adjunctive Effects of Systemic Amoxicillin and Metronidazole with Scaling and Root Planing: A Randomized, Placebo Controlled Clinical Trial. J Contemp Dent Pract 2007; 8 (5):51-59.

DOI: 10.5005/jcdp-8-5-51

License: CC BY-NC 3.0

Published Online: 00-07-2007

Copyright Statement:  Copyright © 2007; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aims

Aims: The objective of this study was to investigate the effect of the systemic administration of metronidazole and amoxicillin as an adjunct to initial periodontal therapy in patients with moderate to severe chronic periodontitis.

Methods and Materials

This randomized, double blind, placebo controlled parallel study involved 50 adult patients with untreated periodontitis who were randomly assigned to receive either a full-mouth scaling and root planing along with systemic metronidazole and amoxicillin (T group) or scaling and root planing with a placebo (P group). Clinical measurements including probing depth (PD), clinical attachment levels (CAL), Plaque Index (PI), and Bleeding Index (BI) were recorded at baseline and six to eight weeks after therapy. The deepest pocket was selected and samples for microbiological testing were taken. Patients received coded study medications of either 500 mg amoxicillin in combination with 250 mg metronidazole or an identical placebo every eight hours for seven days following scaling and root planing.

Results

There was a significant change in PD (P=0.0001), CAL (P=0.00001), PI (P<0.05), and BI (P<0.05) in the T group compared to the placebo group after therapy. Parallel to the clinical changes, treatment significantly reduced the number of Actinobacillus actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), and P. intermedia (Pi) compared with baseline in the T group (P=0.003, 0.021 and 0.0001, respectively). However, in the P group only the Pi colony count was reduced significantly (P=0.0001). After therapy, there was a significant difference between the T and P groups in the number of patients negative for Aa, Pg, and Pi (Pv = 0.033).

Conclusions

The significant differences between treatment and placebo groups are in line with other studies and support the considerable adjunctive benefits of the combination of amoxicillin and metronidazole in the treatment of chronic periodontitis.

Citation

Moeintaghavi A, Talebi-ardakani MR, Haerian-ardakani A, Zandi H, Taghipour S, Fallahzadeh H, Pakzad A, Fahami N. Adjunctive Effects of Systemic Amoxicillin and Metronidazole with Scaling and Root Planing: A Randomized, Placebo Controlled Clinical Trial. J Contemp Dent Pract 2007 July;(8)5:051-059.


PDF Share
  1. Periodontal Diseases: Epidemiology. Proceedings of the 1996 World Workshop in Periodontics. Annals of Periodontology 1996;1:1.36.
  2. Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study. J Clin Periodontol 2002;29:342.350.
  3. Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy. J Clin Periodontol 1998;25:857-864.
  4. Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo- controlled study. J Clin Periodontol 2001;28:296-305.
  5. Relation of baseline microbial parameters to future periodontal attachment loss. J Clin Periodontol 1991;18:744-750.
  6. Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol 1994;65:260-267.
  7. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994;5:78-111.
  8. Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol 1997;24:102-109.
  9. Treatment of periodontal disease based on microbiological diagnosis. A 5 years follow-up on individual patterns. J Periodontol 1996;67:879-887.
  10. Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. II. Correlation between immunofluorescence and culture techniques. J Periodontol. 1987;58:540-545.
  11. Bacterial invasion in root cementum and radicular dentin of periodontally diseased teeth in humans. A reservoir of periodontopathic bacteria. J Periodontol. 1988;59:222-230.
  12. The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial. J Clin Periodontol. 1998;25:354-362.
  13. Antibiotics in the treatment of human periodontal diseases. J Periodontol 1981;52:545.558.
  14. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol 1990;17:479.493.
  15. Current status of antibiotic usage in destructive periodontal disease. J Periodontol 1993;64:760.771.
  16. Local and systemic chemotherapy in the management of periodontal disease. An opinion and review of the concept. J Oral Rehab 1996;23:219.231.
  17. The systemic use of antibiotics in periodontal therapy. In: Proceedings of the 2nd European Workshop on Periodontology 1997. eds.Lang, N. P., Karring, T. & Lindhe, J., pp. 38.77. Quintessence: Berlin.
  18. Systemic antibiotic therapy in periodontics. Periodontol 2000 1996;10:45-78.
  19. The microbiological case for adjunctive therapy for periodontitis. J Int Acad Periodontol 2004 Oct; 6(4 Suppl):143-9.
  20. Microbiological and clinical results of metronidazole plus amoxycillin therapy in Actinobacillus actinomycetemcomitans associated periodontitis. J Periodontol 1992;63:52.57.
  21. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1989;16:128.131.
  22. Short-term systemic administration of Augmentin and doxycycline in the treatment of recurrent progressive periodontitis. J Dent Res 1992;71:319.
  23. Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol 1994a; 21: 107-112.
  24. J Periodontol 2004;75:1553-1565.
  25. Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically administered amoxicillin or metronidazole. J Clin Periodontol 2001;28:297-609.
  26. Metronidazole concentrations in plasma, saliva and periodontal pockets in patients with periodontitis. J Clin Periodontol 2005;32:163-166.
  27. Antibiotic susceptibility testing of subgingival plaque samples. J Clin Periodontol 1983;10:422-432.
  28. Antibiotic susceptibilities of periodontal bacteria. In Vitro susceptibilities to eight antimicrobial agents. J Periodontol 1985;56:67-74.
  29. Periodontal antimicrobials - finding the right solutions. Int Dent J 2005;55:3-12.
  30. Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis. J Clin Periodontol 1998;25:380-387.
  31. Differential effects of systemic metronidazole and amoxicilli9n on Actinobacillus actinomycetemcomitans and porphyromonas gingivalis in intraoral habitats. J Clin Periodontol 1998;25:1-10.
  32. Repeated metronidazole and amoxicillin treatment of periodontitis. A follow-up study. J Periodontol 2000;71:79-89.
  33. Effects of metronidazole plus amoxicillin as the only therapy on the microbiological and clinical parameters of untreated chronic periodontitis. J Clin Periodontol 2006 Jul 20.
  34. Effectiveness of antimicrobial adjuncts to scaling and root-planing therapy for periodontitis. Evid Rep Technol Assess (Summ). 2004;88:1-4.
  35. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 2003;8:115-81.
  36. A systematic review on the effect of systemic antimicrobials as an adjunct to scaling and root planing in periodontitis patients. J Clin Periodontol 2002; 29 Suppl 3:136-59.
  37. A clinical system for scoring a patient.s oral hygiene performance. J Am Dent Assoc. 1973;86:849-852.
  38. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121-135.
  39. Wadsworth Anaerobic Bacteriology Manual, 5th ed. Star pub co. Belmont CA, 1993:30-35, 98-103.
  40. Bailey and Scott‘s Diagnostic Microbiology, 11th ed. Mosby Inc, ST. Louis, 2002:455-458, 520-525, 528-531.
  41. Textbook of Diagnostic Microbiology, 2nd ed. W.B. Saunders, Philadelphia, 2000:436-437, 583-590, 609-610.
  42. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 1997;24:158-165.
  43. Evidence based dentistry for effective practice. Martin Dunitz, London, 2003:199-213.
  44. The effect of periodontal treatment on periodontal bacteria on the oral mucous membranes. J Periodontol 1996;67:478-85.
  45. Microbial etiological agents of destructive periodontal diseases. Periodontol 2000 1994; 5: 78-111.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.